Cognitive Flexibility in Depression and TMS Response

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

March 15, 2024

Study Completion Date

March 15, 2024

Conditions
Depression - Major Depressive DisorderCognitive FlexibilityTreatment ResponseSide Effects
Interventions
DEVICE

Transcranial Magnetic Stimulation

Transcranial Magnetic Stimulation (TMS) is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain. It is primarily used to treat depression, particularly in patients who have not responded to traditional treatments such as selective serotonin reuptake inhibitors (SSRIs) or psychotherapy. The most common target area is the dorsolateral prefrontal cortex, which is often underactive in individuals with depression. TMS devices, such as the FDA-approved Magventure system, deliver magnetic pulses to stimulate or inhibit brain activity in the targeted region. This process is believed to help reset or normalize patterns of neural activity associated with depression and other psychiatric disorders. TMS offers a promising alternative for individuals struggling with depression, providing a non-invasive approach with relatively few side effects and notable potential benefits.

Trial Locations (1)

06000

Gulhane Training and Research Hospital, Ankara

All Listed Sponsors
lead

Gulhane Training and Research Hospital

OTHER_GOV